<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-29091" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Skin Cancer</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Gruber</surname>
            <given-names>Paul</given-names>
          </name>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Zito</surname>
            <given-names>Patrick M.</given-names>
          </name>
          <aff>University of Miami; Miller School of Medicine</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Paul Gruber declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Patrick Zito declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>14</day>
          <month>5</month>
          <year>2023</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-29091.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p>Skin cancer is the most common form of cancer in the United States and is generally classified as nonmelanoma skin cancer (NMSC) or melanoma. This activity provides a broad overview of skin cancer and reviews epidemiology, risk factors, pathogenesis, and treatment. This activity highlights the role of the interprofessional interprofessional team in managing patients with skin cancer.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Identify the risk factors for the development of both nonmelanoma and melanoma skin cancers.</p></list-item><list-item><p>Describe the common physical examination findings in actinic keratosis, squamous cell carcinoma, basal cell carcinoma, and melanoma.</p></list-item><list-item><p>Summarize the treatment and management options available for skin cancer.</p></list-item><list-item><p>Explain interprofessional team strategies for improving care coordination and communication in the management of skin cancer.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/viewarticle/29091/?utm_source=pubmed&#x00026;utm_campaign=CME&#x00026;utm_content=29091">Earn FREE continuing education credits (CME/CE) on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-29091.s2" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>Skin cancer is the most common form of cancer in the United States. Skin cancer is generally classified as nonmelanoma skin cancer (NMSC) or melanoma. The exact incidence of&#x000a0;skin cancer is difficult to determine due to the lack of diagnostic criteria and underreporting. However, several epidemiologic studies have shown&#x000a0;an increasing&#x000a0;incidence of&#x000a0;both NMSC and melanoma over the past several decades.<xref ref-type="bibr" rid="article-29091.r1">[1]</xref><xref ref-type="bibr" rid="article-29091.r2">[2]</xref>&#x000a0;The diagnosis and treatment of these neoplasms represent a significant health problem from the standpoint of patient well-being and healthcare expenditures. Skin cancers&#x000a0;are frequently&#x000a0;located on the sun-exposed head and neck regions, which can result in significant morbidity during their diagnosis and treatment. Treatment options include surgical excision, cryotherapy, chemotherapy, immunotherapy, and radiation.&#x000a0;Proper sun safety (i.e., sunscreen) is of the utmost importance to prevent skin cancer.</p>
      </sec>
      <sec id="article-29091.s3" sec-type="Etiology">
        <title>Etiology</title>
        <p>Ultraviolet (UV) solar radiation is the major etiologic factor in the development of cutaneous malignancies.&#x000a0;An overwhelming majority of cases of NMSC and melanoma are related to UV exposure.<xref ref-type="bibr" rid="article-29091.r3">[3]</xref><xref ref-type="bibr" rid="article-29091.r4">[4]</xref>&#x000a0;UV exposure induces carcinogenesis by a twofold mechanism; it generates DNA damage that leads to mutation formation and reduces the ability of the host immune system to recognize and remove malignant cells.&#x000a0;Basal cell carcinoma (BCC) and squamous cell carcinoma (SCC) are the most common forms of NMSC, and both are derived from mutated epidermal keratinocytes. The cumulative lifetime UV exposure is directly correlated with the risk of developing BCC and SCC. Melanoma is the deadliest form of skin and is derived from mutated melanocytes. In contrast to BCC and SCC, the risk of developing melanoma is directly correlated with sun exposure during&#x000a0;adolescence, specifically the number of sunburns aged 15 to 20.<xref ref-type="bibr" rid="article-29091.r5">[5]</xref>&#x000a0;Other risk factors implicated in the development of cutaneous malignancies include family history, chemical exposure, tanning bed use, human papillomavirus (HPV), Fitzpatrick skin type, the presence of melanocytic nevi, and immunosuppressed status.<xref ref-type="bibr" rid="article-29091.r6">[6]</xref></p>
      </sec>
      <sec id="article-29091.s4" sec-type="Epidemiology">
        <title>Epidemiology</title>
        <p>There are more skin cancers in the United States population than all other cancers combined.<xref ref-type="bibr" rid="article-29091.r7">[7]</xref> These cancers are on the rise, representing a significant health problem from the standpoint of patient well-being and health expenditures.<xref ref-type="bibr" rid="article-29091.r8">[8]</xref> Skin cancer occurs in all races worldwide. However, the risk is substantially higher in Whites due to the photoprotective effects of epidermal melanin.<xref ref-type="bibr" rid="article-29091.r9">[9]</xref> In individuals with fair skin, approximately 75% to 80% of non-melanoma skin cancers are basal cell carcinomas, and up to 25% are squamous cell carcinomas. Heritable defects in DNA repair mechanisms, as seen in xeroderma pigmentosum and Muir-Torre Syndrome, also put afflicted individuals at high risk for cutaneous carcinomas.&#x000a0;</p>
      </sec>
      <sec id="article-29091.s5" sec-type="Pathophysiology">
        <title>Pathophysiology</title>
        <p>Sun exposure is the most important modifiable risk factor associated with the development of NMSC and melanoma. UV radiation can be subdivided into UV-A, UV-B, and UV-C. Sunlight is primarily composed of the&#x000a0;UV-A (~90%)&#x000a0;and UV-B (~10%) components.<xref ref-type="bibr" rid="article-29091.r3">[3]</xref> UV-C rays are mostly absorbed by the atmosphere. UV-A has a longer wavelength (320-400 nm) and penetrates the dermis, causing the formation of free radicals. UV-B has a shorter wavelength (290-320 nm), penetrates to the level of the stratum basale of the epidermis, and causes the formation of thymine dimers. Both UV-A and UV-B contribute to carcinogenesis. However, UV-A is thought to play a larger role. UV radiation causes cell injury and apoptosis and impairs DNA repair mechanisms, leading to DNA mutations.&#x000a0;</p>
        <p>The development of cutaneous malignancy after DNA damage by solar radiation is multifactorial, including genetic factors, Fitzpatrick skin type, and immunosuppressed status. Most (90%) of cutaneous squamous cell carcinoma have UV-induced P53 gene mutations leading to the uninhibited proliferation of keratinocytes.<xref ref-type="bibr" rid="article-29091.r10">[10]</xref> DNA mutations implicated in basal cell carcinoma include&#x000a0;mutations in the PTCH gene and the p53 gene.<xref ref-type="bibr" rid="article-29091.r11">[11]</xref>&#x000a0;DNA mutations implicated in melanoma include mutations in cyclin-dependent kinase Inhibitor 2A (CDKN2A), melanocortin receptor 1 (MCR1), B-Raf, and DNA repair enzymes (e.g., UV-specific endonuclease&#x000a0;in xeroderma pigmentosum).<xref ref-type="bibr" rid="article-29091.r12">[12]</xref><xref ref-type="bibr" rid="article-29091.r13">[13]</xref></p>
      </sec>
      <sec id="article-29091.s6" sec-type="History and Physical">
        <title>History and Physical</title>
        <p>A thorough skin examination is useful to identify premalignant and malignant skin lesions. It is important to note the location, texture, size, color, shape, borders, and any recent change&#x000a0;of suspicious lesions. Premalignant actinic keratoses often present as rough, gritty skin papules on an erythematous base. Basal cell carcinomas usually appear as pink pearly papules with telangiectasias. Squamous cell carcinomas are often pink, rough papules, patches, and plaques. Melanomas are characteristically brown-to-black lesions with asymmetry, irregular borders, color variegation, and diameters greater than 6 mm. Any new/changing lesion or lesion that appears different than other nevi on the body ("ugly duckling sign")&#x000a0;is considered suspicious.<xref ref-type="bibr" rid="article-29091.r14">[14]</xref></p>
        <p>Basal cell carcinomas and squamous cell carcinomas&#x000a0;are commonly noted on parts of the head and neck that receive the most cumulative UV&#x000a0; radiation over the course of a lifetime, such as the nose, ear, and upper lip. Melanomas can occur anywhere on the body and are most frequently&#x000a0;discovered on the backs and shoulders of men and the lower limbs of women.<xref ref-type="bibr" rid="article-29091.r15">[15]</xref> However, studies comparing the risk of melanoma per unit area of skin have found the face to be the highest risk area for melanoma.<xref ref-type="bibr" rid="article-29091.r16">[16]</xref>&#x000a0;&#x000a0;</p>
      </sec>
      <sec id="article-29091.s7" sec-type="Evaluation">
        <title>Evaluation</title>
        <p>Evaluation of patients at risk for cutaneous carcinoma usually includes a full body skin examination by a medical professional. This can be done by most primary care providers; however, the evaluation is often performed by specialists with three years of post-medical school advanced dermatology training. The vast majority of concerning lesions on physical examination will undergo an office procedure called a skin biopsy. This is done under local anesthesia during an outpatient office visit. The specimen is then sent for special interpretation by a trained dermatopathologist. If the pathologist reading the tissue specimen under the microscope confirms the diagnosis of cutaneous malignancy, further intervention is usually warranted based on the pathologic diagnosis and clinical scenario.</p>
      </sec>
      <sec id="article-29091.s8" sec-type="Treatment / Management">
        <title>Treatment / Management</title>
        <p>Treatment of precancerous lesions and cutaneous carcinoma should be tailored toward the individual patient scenario and the best clinical outcome. If presenting as isolated lesions, precancerous actinic keratoses can be treated with lesion-directed therapies such as cryotherapy.<xref ref-type="bibr" rid="article-29091.r17">[17]</xref> Often, patients may present with numerous lesions and diffuse actinic damage, which requires field-directed therapy as opposed to individually treating each lesion.<xref ref-type="bibr" rid="article-29091.r17">[17]</xref> &#x000a0;This can be done with topical agents (5-fluorouracil, imiquimod, and ingenol mebutate) or with photodynamic therapy after sensitizing the skin with a topical agent. Initial pre-emptive efforts should be made to reduce the patient's risk profile for developing cutaneous carcinoma, including optimizing the immunosuppressant regimen in solid organ transplant patients, proper surveillance schedules in patients treated with immunomodulatory therapies and adequate therapy of precancerous lesions.&#x000a0;</p>
        <p>Basal cell carcinomas and squamous cell carcinomas, if superficial, can be treated with topical therapies depending on provider preference. However, the standard practice is to surgically treat these lesions with destructive means such as electrodesiccation and curettage or surgical excision. Skin cancers greater than 2 cm in diameter and those located on functionally and cosmetically sensitive sites (head/neck, hands, feet, genitalia) are usually referred for a special surgical procedure called Mohs micrographic surgery.<xref ref-type="bibr" rid="article-29091.r18">[18]</xref> Some patients with aggressive and recurrent forms of basal cell carcinoma who&#x000a0;are not good surgical candidates are treated with radiation therapy or systemic medications (e.g., vismodegib for basal cell carcinoma).<xref ref-type="bibr" rid="article-29091.r19">[19]</xref>&#x000a0;</p>
        <p>Melanoma&#x000a0;is the most aggressive&#x000a0;and lethal form of cancer, and&#x000a0;the gold standard of treatment is surgical excision. If caught early, surgical excision can be curative. Later stage tumors portend a poor prognosis and often require adjuvant chemotherapy or immunotherapy.<xref ref-type="bibr" rid="article-29091.r20">[20]</xref></p>
      </sec>
      <sec id="article-29091.s9" sec-type="Differential Diagnosis">
        <title>Differential Diagnosis</title>
        <list list-type="bullet">
          <list-item>
            <p>Psoriasis</p>
          </list-item>
          <list-item>
            <p>Seborrheic keratoses</p>
          </list-item>
          <list-item>
            <p>Sebaceous hyperplasia</p>
          </list-item>
          <list-item>
            <p>Nevus</p>
          </list-item>
          <list-item>
            <p>Cherry angioma</p>
          </list-item>
          <list-item>
            <p>
Benign melanocytic lesions
</p>
          </list-item>
          <list-item>
            <p>
Dysplastic nevus
</p>
          </list-item>
          <list-item>
            <p>
Metastatic tumors to the skin
</p>
          </list-item>
          <list-item>
            <p>
Epithelioid tumor
</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-29091.s10" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>Skin cancers are frequently encountered in clinical practice by the primary care provider, nurse practitioner, and internist. In all cases, the patient should be referred to a dermatologist for final confirmation. While the treatment of skin cancer is done by an oncologist and a dermatologist, the primary care providers play a vital role in prevention. Patients should be educated about avoiding too much sun, wearing appropriate garments when going outdoors, and applying sunscreen. Finally, patients should be educated on how to inspect their skin and when to seek medical assistance.&#x000a0;<xref ref-type="bibr" rid="article-29091.r21">[21]</xref></p>
      </sec>
      <sec id="article-29091.s11">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=29091&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=29091">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/home/freecme/?utm_source=pubmed&#x00026;utm_campaign=FREECME&#x00026;utm_content=29091">Access free CME on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://mdsearchlight.com/cancer/skin-cancer/?utm_source=pubmedlink&#x00026;utm_campaign=MDS&#x00026;utm_content=29091">Click here for a simplified version.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/29091/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=29091">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <ref-list id="article-29091.s12">
        <title>References</title>
        <ref id="article-29091.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Rogers</surname>
                <given-names>HW</given-names>
              </name>
              <name>
                <surname>Weinstock</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Feldman</surname>
                <given-names>SR</given-names>
              </name>
              <name>
                <surname>Coldiron</surname>
                <given-names>BM</given-names>
              </name>
            </person-group>
            <article-title>Incidence Estimate of Nonmelanoma Skin Cancer (Keratinocyte Carcinomas) in the U.S. Population, 2012.</article-title>
            <source>JAMA Dermatol</source>
            <year>2015</year>
            <month>Oct</month>
            <volume>151</volume>
            <issue>10</issue>
            <fpage>1081</fpage>
            <page-range>1081-6</page-range>
            <pub-id pub-id-type="pmid">25928283</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29091.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Glazer</surname>
                <given-names>AM</given-names>
              </name>
              <name>
                <surname>Winkelmann</surname>
                <given-names>RR</given-names>
              </name>
              <name>
                <surname>Farberg</surname>
                <given-names>AS</given-names>
              </name>
              <name>
                <surname>Rigel</surname>
                <given-names>DS</given-names>
              </name>
            </person-group>
            <article-title>Analysis of Trends in US Melanoma Incidence and Mortality.</article-title>
            <source>JAMA Dermatol</source>
            <year>2017</year>
            <month>Feb</month>
            <day>01</day>
            <volume>153</volume>
            <issue>2</issue>
            <fpage>225</fpage>
            <page-range>225-226</page-range>
            <pub-id pub-id-type="pmid">28002545</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29091.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>D'Orazio</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Jarrett</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Amaro-Ortiz</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Scott</surname>
                <given-names>T</given-names>
              </name>
            </person-group>
            <article-title>UV radiation and the skin.</article-title>
            <source>Int J Mol Sci</source>
            <year>2013</year>
            <month>Jun</month>
            <day>07</day>
            <volume>14</volume>
            <issue>6</issue>
            <fpage>12222</fpage>
            <page-range>12222-48</page-range>
            <pub-id pub-id-type="pmid">23749111</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29091.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Armstrong</surname>
                <given-names>BK</given-names>
              </name>
              <name>
                <surname>Kricker</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>How much melanoma is caused by sun exposure?</article-title>
            <source>Melanoma Res</source>
            <year>1993</year>
            <month>Dec</month>
            <volume>3</volume>
            <issue>6</issue>
            <fpage>395</fpage>
            <page-range>395-401</page-range>
            <pub-id pub-id-type="pmid">8161879</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29091.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wu</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Han</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Laden</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Qureshi</surname>
                <given-names>AA</given-names>
              </name>
            </person-group>
            <article-title>Long-term ultraviolet flux, other potential risk factors, and skin cancer risk: a cohort study.</article-title>
            <source>Cancer Epidemiol Biomarkers Prev</source>
            <year>2014</year>
            <month>Jun</month>
            <volume>23</volume>
            <issue>6</issue>
            <fpage>1080</fpage>
            <page-range>1080-9</page-range>
            <pub-id pub-id-type="pmid">24876226</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29091.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Saladi</surname>
                <given-names>RN</given-names>
              </name>
              <name>
                <surname>Persaud</surname>
                <given-names>AN</given-names>
              </name>
            </person-group>
            <article-title>The causes of skin cancer: a comprehensive review.</article-title>
            <source>Drugs Today (Barc)</source>
            <year>2005</year>
            <month>Jan</month>
            <volume>41</volume>
            <issue>1</issue>
            <fpage>37</fpage>
            <page-range>37-53</page-range>
            <pub-id pub-id-type="pmid">15753968</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29091.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gordon</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>Skin cancer: an overview of epidemiology and risk factors.</article-title>
            <source>Semin Oncol Nurs</source>
            <year>2013</year>
            <month>Aug</month>
            <volume>29</volume>
            <issue>3</issue>
            <fpage>160</fpage>
            <page-range>160-9</page-range>
            <pub-id pub-id-type="pmid">23958214</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29091.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Guy</surname>
                <given-names>GP</given-names>
              </name>
              <name>
                <surname>Machlin</surname>
                <given-names>SR</given-names>
              </name>
              <name>
                <surname>Ekwueme</surname>
                <given-names>DU</given-names>
              </name>
              <name>
                <surname>Yabroff</surname>
                <given-names>KR</given-names>
              </name>
            </person-group>
            <article-title>Prevalence and costs of skin cancer treatment in the U.S., 2002-2006 and 2007-2011.</article-title>
            <source>Am J Prev Med</source>
            <year>2015</year>
            <month>Feb</month>
            <volume>48</volume>
            <issue>2</issue>
            <fpage>183</fpage>
            <page-range>183-187</page-range>
            <pub-id pub-id-type="pmid">25442229</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29091.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bradford</surname>
                <given-names>PT</given-names>
              </name>
            </person-group>
            <article-title>Skin cancer in skin of color.</article-title>
            <source>Dermatol Nurs</source>
            <year>2009</year>
            <season>Jul-Aug</season>
            <volume>21</volume>
            <issue>4</issue>
            <fpage>170</fpage>
            <page-range>170-7, 206; quiz 178</page-range>
            <pub-id pub-id-type="pmid">19691228</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29091.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Black</surname>
                <given-names>AP</given-names>
              </name>
              <name>
                <surname>Ogg</surname>
                <given-names>GS</given-names>
              </name>
            </person-group>
            <article-title>The role of p53 in the immunobiology of cutaneous squamous cell carcinoma.</article-title>
            <source>Clin Exp Immunol</source>
            <year>2003</year>
            <month>Jun</month>
            <volume>132</volume>
            <issue>3</issue>
            <fpage>379</fpage>
            <page-range>379-84</page-range>
            <pub-id pub-id-type="pmid">12780682</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29091.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kim</surname>
                <given-names>MY</given-names>
              </name>
              <name>
                <surname>Park</surname>
                <given-names>HJ</given-names>
              </name>
              <name>
                <surname>Baek</surname>
                <given-names>SC</given-names>
              </name>
              <name>
                <surname>Byun</surname>
                <given-names>DG</given-names>
              </name>
              <name>
                <surname>Houh</surname>
                <given-names>D</given-names>
              </name>
            </person-group>
            <article-title>Mutations of the p53 and PTCH gene in basal cell carcinomas: UV mutation signature and strand bias.</article-title>
            <source>J Dermatol Sci</source>
            <year>2002</year>
            <month>May</month>
            <volume>29</volume>
            <issue>1</issue>
            <fpage>1</fpage>
            <page-range>1-9</page-range>
            <pub-id pub-id-type="pmid">12007715</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29091.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ascierto</surname>
                <given-names>PA</given-names>
              </name>
              <name>
                <surname>Kirkwood</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Grob</surname>
                <given-names>JJ</given-names>
              </name>
              <name>
                <surname>Simeone</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Grimaldi</surname>
                <given-names>AM</given-names>
              </name>
              <name>
                <surname>Maio</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Palmieri</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Testori</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Marincola</surname>
                <given-names>FM</given-names>
              </name>
              <name>
                <surname>Mozzillo</surname>
                <given-names>N</given-names>
              </name>
            </person-group>
            <article-title>The role of BRAF V600 mutation in melanoma.</article-title>
            <source>J Transl Med</source>
            <year>2012</year>
            <month>Jul</month>
            <day>09</day>
            <volume>10</volume>
            <fpage>85</fpage>
            <pub-id pub-id-type="pmid">22554099</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29091.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Helgadottir</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Olsson</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Tucker</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Yang</surname>
                <given-names>XR</given-names>
              </name>
              <name>
                <surname>H&#x000f6;iom</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Goldstein</surname>
                <given-names>AM</given-names>
              </name>
            </person-group>
            <article-title>Phenocopies in melanoma-prone families with germ-line CDKN2A mutations.</article-title>
            <source>Genet Med</source>
            <year>2018</year>
            <month>Sep</month>
            <volume>20</volume>
            <issue>9</issue>
            <fpage>1087</fpage>
            <page-range>1087-1090</page-range>
            <pub-id pub-id-type="pmid">29215650</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29091.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Daniel Jensen</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Elewski</surname>
                <given-names>BE</given-names>
              </name>
            </person-group>
            <article-title>The ABCDEF Rule: Combining the "ABCDE Rule" and the "Ugly Duckling Sign" in an Effort to Improve Patient Self-Screening Examinations.</article-title>
            <source>J Clin Aesthet Dermatol</source>
            <year>2015</year>
            <month>Feb</month>
            <volume>8</volume>
            <issue>2</issue>
            <fpage>15</fpage>
            <pub-id pub-id-type="pmid">25741397</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29091.r15">
          <label>15</label>
          <element-citation publication-type="book">
            <person-group person-group-type="author">
              <name>
                <surname>Matthews</surname>
                <given-names>NH</given-names>
              </name>
              <name>
                <surname>Li</surname>
                <given-names>WQ</given-names>
              </name>
              <name>
                <surname>Qureshi</surname>
                <given-names>AA</given-names>
              </name>
              <name>
                <surname>Weinstock</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Cho</surname>
                <given-names>E</given-names>
              </name>
            </person-group>
            <chapter-title>Epidemiology of Melanoma</chapter-title>
            <person-group person-group-type="editor">
              <name>
                <surname>Ward</surname>
                <given-names>WH</given-names>
              </name>
              <name>
                <surname>Farma</surname>
                <given-names>JM</given-names>
              </name>
            </person-group>
            <source>Cutaneous Melanoma: Etiology and Therapy [Internet]</source>
            <publisher-name>Codon Publications</publisher-name>
            <publisher-loc>Brisbane (AU)</publisher-loc>
            <year>2017</year>
            <month>12</month>
            <day>21</day>
            <pub-id pub-id-type="pmid">29461782</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29091.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Green</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>MacLennan</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Youl</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Martin</surname>
                <given-names>N</given-names>
              </name>
            </person-group>
            <article-title>Site distribution of cutaneous melanoma in Queensland.</article-title>
            <source>Int J Cancer</source>
            <year>1993</year>
            <month>Jan</month>
            <day>21</day>
            <volume>53</volume>
            <issue>2</issue>
            <fpage>232</fpage>
            <page-range>232-6</page-range>
            <pub-id pub-id-type="pmid">8425760</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29091.r17">
          <label>17</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Peris</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Fargnoli</surname>
                <given-names>MC</given-names>
              </name>
            </person-group>
            <article-title>Conventional treatment of actinic keratosis: an overview.</article-title>
            <source>Curr Probl Dermatol</source>
            <year>2015</year>
            <volume>46</volume>
            <fpage>108</fpage>
            <page-range>108-14</page-range>
            <pub-id pub-id-type="pmid">25561214</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29091.r18">
          <label>18</label>
          <element-citation publication-type="book">
            <person-group person-group-type="author">
              <name>
                <surname>Prickett</surname>
                <given-names>KA</given-names>
              </name>
              <name>
                <surname>Ramsey</surname>
                <given-names>ML</given-names>
              </name>
            </person-group>
            <chapter-title>Mohs Micrographic Surgery</chapter-title>
            <source>StatPearls [Internet]</source>
            <publisher-name>StatPearls Publishing</publisher-name>
            <publisher-loc>Treasure Island (FL)</publisher-loc>
            <year>2023</year>
            <month>7</month>
            <day>25</day>
            <pub-id pub-id-type="pmid">28722863</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29091.r19">
          <label>19</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Frampton</surname>
                <given-names>JE</given-names>
              </name>
              <name>
                <surname>Basset-S&#x000e9;guin</surname>
                <given-names>N</given-names>
              </name>
            </person-group>
            <article-title>Vismodegib: A Review in Advanced Basal Cell Carcinoma.</article-title>
            <source>Drugs</source>
            <year>2018</year>
            <month>Jul</month>
            <volume>78</volume>
            <issue>11</issue>
            <fpage>1145</fpage>
            <page-range>1145-1156</page-range>
            <pub-id pub-id-type="pmid">30030732</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29091.r20">
          <label>20</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lugowska</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Teterycz</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Rutkowski</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>Immunotherapy of melanoma.</article-title>
            <source>Contemp Oncol (Pozn)</source>
            <year>2018</year>
            <month>Mar</month>
            <volume>22</volume>
            <issue>1A</issue>
            <fpage>61</fpage>
            <page-range>61-67</page-range>
            <pub-id pub-id-type="pmid">29628796</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29091.r21">
          <label>21</label>
          <element-citation publication-type="book">
            <collab>PDQ Screening and Prevention Editorial Board</collab>
            <chapter-title>Skin Cancer Prevention (PDQ&#x000ae;): Health Professional Version</chapter-title>
            <source>PDQ Cancer Information Summaries [Internet]</source>
            <publisher-name>National Cancer Institute (US)</publisher-name>
            <publisher-loc>Bethesda (MD)</publisher-loc>
            <year>2024</year>
            <month>3</month>
            <day>7</day>
            <pub-id pub-id-type="pmid">26389494</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
